Lidocaine and Prevention of Chronic Pain
CompletedNot applicableNCT01619852
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study seeks to investigate a safe and inexpensive strategy to reduce persistent post-surgical pain that can affect up to 60% of patients undergoing surgical procedures. Hypotheses: Perioperative systemic lidocaine reduces the persistence of chronic pain in patients undergoing surgical procedures.
Study details
- Official title
- The Effect of Lidocaine to Prevent the Development of Chronic Post-Surgical Pain
- Conditions
- Interventions
- Drug: .9 normal saline placebo
- Drug: Group L (lidocaine)
- Sponsor
- Northwestern University
- Start date
- 2012-06
- Primary completion
- 2014-07
- Sex
- Female
- Age range
- from 18 Years to 64 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18-64, * Females undergoing gynecological, urological or breast surgery Exclusion Criteria: * pregnant, * history of chronic use of opioids, * allergy to local anesthetics, * history of cardiac arrhythmias Drop out: patient or surgeon request
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01619852